5.26 USD
-0.16 (-2.95%)
5.3 USD
+0.04 (+0.76%)
We assign a fundamental rating of 6 out of 10 to MDXG. MDXG was compared to 525 industry peers in the Biotechnology industry. While MDXG has a great health rating, its profitability is only average at the moment. MDXG scores decently on growth, while it is valued quite cheap. This could make an interesting combination. With these ratings, MDXG could be worth investigating further for value investing!.
1. Profitability
1.1 Basic Checks
- MDXG had positive earnings in the past year.
- MDXG had a positive operating cash flow in the past year.
- In multiple years MDXG reported negative net income over the last 5 years.
- The reported operating cash flow has been mixed in the past 5 years: MDXG reported negative operating cash flow in multiple years.
1.2 Ratios
- MDXG's Return On Assets of 12.80% is amongst the best of the industry. MDXG outperforms 94.48% of its industry peers.
- With an excellent Return On Equity value of 17.09%, MDXG belongs to the best of the industry, outperforming 95.05% of the companies in the same industry.
- The Return On Invested Capital of MDXG (15.15%) is better than 95.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.8% | ||
| ROE | 17.09% | ||
| ROIC | 15.15% |
ROA(3y)4.7%
ROA(5y)-7.18%
ROE(3y)1.74%
ROE(5y)-20.73%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin of MDXG (10.38%) is better than 91.43% of its industry peers.
- With an excellent Operating Margin value of 13.73%, MDXG belongs to the best of the industry, outperforming 92.95% of the companies in the same industry.
- In the last couple of years the Operating Margin of MDXG has remained more or less at the same level.
- The Gross Margin of MDXG (81.99%) is better than 85.71% of its industry peers.
- In the last couple of years the Gross Margin of MDXG has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.73% | ||
| PM (TTM) | 10.38% | ||
| GM | 81.99% |
OM growth 3YN/A
OM growth 5Y-1.06%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.19%
GM growth 5Y-0.67%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so MDXG is still creating some value.
- Compared to 1 year ago, MDXG has more shares outstanding
- MDXG has more shares outstanding than it did 5 years ago.
- MDXG has a better debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 8.29 indicates that MDXG is not in any danger for bankruptcy at the moment.
- With a decent Altman-Z score value of 8.29, MDXG is doing good in the industry, outperforming 79.05% of the companies in the same industry.
- The Debt to FCF ratio of MDXG is 0.27, which is an excellent value as it means it would take MDXG, only 0.27 years of fcf income to pay off all of its debts.
- MDXG has a better Debt to FCF ratio (0.27) than 95.43% of its industry peers.
- A Debt/Equity ratio of 0.07 indicates that MDXG is not too dependend on debt financing.
- MDXG's Debt to Equity ratio of 0.07 is on the low side compared to the rest of the industry. MDXG is outperformed by 60.95% of its industry peers.
- Although MDXG does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | 0.27 | ||
| Altman-Z | 8.29 |
ROIC/WACC1.73
WACC8.77%
2.3 Liquidity
- MDXG has a Current Ratio of 4.41. This indicates that MDXG is financially healthy and has no problem in meeting its short term obligations.
- MDXG has a Current ratio (4.41) which is comparable to the rest of the industry.
- MDXG has a Quick Ratio of 3.95. This indicates that MDXG is financially healthy and has no problem in meeting its short term obligations.
- MDXG has a Quick ratio of 3.95. This is comparable to the rest of the industry: MDXG outperforms 48.95% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.41 | ||
| Quick Ratio | 3.95 |
3. Growth
3.1 Past
- The earnings per share for MDXG have decreased strongly by -35.71% in the last year.
- MDXG shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.77%.
- MDXG shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.11% yearly.
EPS 1Y (TTM)-35.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
Revenue 1Y (TTM)14.77%
Revenue growth 3Y10.5%
Revenue growth 5Y3.11%
Sales Q2Q%35.3%
3.2 Future
- Based on estimates for the next years, MDXG will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.54% on average per year.
- Based on estimates for the next years, MDXG will show a quite strong growth in Revenue. The Revenue will grow by 14.49% on average per year.
EPS Next Y47.72%
EPS Next 2Y-7.17%
EPS Next 3Y16.54%
EPS Next 5YN/A
Revenue Next Year18%
Revenue Next 2Y9.77%
Revenue Next 3Y10.75%
Revenue Next 5Y14.49%
3.3 Evolution
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 14.61, MDXG is valued correctly.
- Compared to the rest of the industry, the Price/Earnings ratio of MDXG indicates a rather cheap valuation: MDXG is cheaper than 96.19% of the companies listed in the same industry.
- When comparing the Price/Earnings ratio of MDXG to the average of the S&P500 Index (27.21), we can say MDXG is valued slightly cheaper.
- Based on the Price/Forward Earnings ratio of 21.05, the valuation of MDXG can be described as rather expensive.
- Based on the Price/Forward Earnings ratio, MDXG is valued cheaply inside the industry as 93.52% of the companies are valued more expensively.
- Compared to an average S&P500 Price/Forward Earnings ratio of 24.26, MDXG is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.61 | ||
| Fwd PE | 21.05 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, MDXG is valued cheaply inside the industry as 97.52% of the companies are valued more expensively.
- Based on the Price/Free Cash Flow ratio, MDXG is valued cheaply inside the industry as 97.90% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.66 | ||
| EV/EBITDA | 9.89 |
4.3 Compensation for Growth
- MDXG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- MDXG has a very decent profitability rating, which may justify a higher PE ratio.
- A more expensive valuation may be justified as MDXG's earnings are expected to grow with 16.54% in the coming years.
PEG (NY)0.31
PEG (5Y)N/A
EPS Next 2Y-7.17%
EPS Next 3Y16.54%
5. Dividend
5.1 Amount
- MDXG does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
MIMEDX GROUP INC / MDXG FAQ
Can you provide the ChartMill fundamental rating for MIMEDX GROUP INC?
ChartMill assigns a fundamental rating of 6 / 10 to MDXG.
Can you provide the valuation status for MIMEDX GROUP INC?
ChartMill assigns a valuation rating of 7 / 10 to MIMEDX GROUP INC (MDXG). This can be considered as Undervalued.
What is the profitability of MDXG stock?
MIMEDX GROUP INC (MDXG) has a profitability rating of 6 / 10.
What is the financial health of MIMEDX GROUP INC (MDXG) stock?
The financial health rating of MIMEDX GROUP INC (MDXG) is 7 / 10.
What is the earnings growth outlook for MIMEDX GROUP INC?
The Earnings per Share (EPS) of MIMEDX GROUP INC (MDXG) is expected to grow by 47.72% in the next year.